APA aipamena

Strand, V., Reaney, M., Chen, C., Proudfoot, C. W. J., Guillonneau, S., Bauer, D., . . . Fleischmann, R. (2017). Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors. RMD Open.

Chicago Style aipamena

Strand, Vibeke, et al. "Sarilumab Improves Patient-reported Outcomes in Rheumatoid Arthritis Patients With Inadequate Response/intolerance to Tumour Necrosis Factor Inhibitors." RMD Open 2017.

MLA aipamena

Strand, Vibeke, et al. "Sarilumab Improves Patient-reported Outcomes in Rheumatoid Arthritis Patients With Inadequate Response/intolerance to Tumour Necrosis Factor Inhibitors." RMD Open 2017.